InterOcean Capital Group’s Novo Nordisk NVO Stock Holding History

InterOcean Capital Group’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	$497K	Sell	3,874 -164	-4%	-$19.5K	0.01%	302
2023 Q4	$418K	Buy	4,038 +254	+7%	+$25.1K	0.01%	321
2023 Q3	$344K	Sell	3,784 -536	-12%	-$47.2K	0.01%	322
2023 Q2	$350K	Buy	4,320 +20	+0.5%	+$1.63K	0.01%	334
2023 Q1	$342K	Sell	4,300 -448	-9%	-$31.8K	0.01%	303
2022 Q4	$321K	Sell	4,748 -64	-1%	-$3.75K	0.01%	312
2022 Q3	$240K	Sell	4,812 -5,142	-52%	-$275K	0.01%	345
2022 Q2	$555K	Buy	+9,954	New	+$552K	0.02%	223

Other funds holding NVO

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Fayez Sarofim & Co Houston, Texas $42.5B AUM 18.19% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

InterOcean Capital Group's NVO Position: Q1 2024 in Review

InterOcean Capital Group reduced its Novo Nordisk (NVO) stake by 4.1% in Q1 2024, selling an estimated $19.5K and leaving 3,874 shares worth $497K. The position accounts for 0.01% of the portfolio, ranked #302.

InterOcean Capital Group first reported a position in NVO in Q2 2022 and has held it in 8 quarters since. The position peaked at $555K in Q2 2022. 1,747 funds tracked by Wall St. Rank hold NVO as of Q1 2024.

InterOcean Capital Group held 3,874 shares of Novo Nordisk worth $497K as of Q1 2024.
InterOcean Capital Group sold 164 Novo Nordisk shares in Q1 2024, an estimated $19.5K.
Novo Nordisk made up 0.01% of InterOcean Capital Group's portfolio in Q1 2024, its #302 holding.
InterOcean Capital Group first reported a position in Novo Nordisk in Q2 2022 and has held it in 8 quarters since.
InterOcean Capital Group's Novo Nordisk position peaked at $555K in Q2 2022.
1,747 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2024.

Based on InterOcean Capital Group's 13F filing for Q1 2024, filed 13 May 2024.